Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-30 @ 4:50 PM
Study NCT ID:
NCT00379067
Status:
COMPLETED
Last Update Posted:
2014-10-10
First Post:
2006-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
Sponsor:
Astellas Pharma Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
617-EC-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None